Exact claim · Version 1 · Reviewed 2026-07-23
“Insulin is an established treatment for diabetes.”
A verdict on this wording and scope, not a universal grade for Insulin.
01 · Verdict
Supported with scope
Multiple insulin products are FDA-approved, and long-term human evidence supports insulin strategies in defined diabetes populations. The exact product and care context still matter.
- Evidence basis
- Randomized human outcomes
- Scope
- FDA-approved insulin products and monitored treatment strategies in defined diabetes populations.
- Category
- Clinical outcomes
02 · Primary record
Check the attached evidence
01Insulin: patient and product overviewU.S. Food and Drug Administration · Regulatory · 2026
Supports the scoped claim02The effect of intensive treatment of diabetes on long-term complications in insulin-dependent diabetes mellitusPubMed · New England Journal of Medicine · Randomized trial · 1993
Supports the scoped claim
Supports the scoped claim02The effect of intensive treatment of diabetes on long-term complications in insulin-dependent diabetes mellitusPubMed · New England Journal of Medicine · Randomized trial · 1993
Supports the scoped claim
- Editorial review
- Internal editorial review recorded
- Responsible editor
- Anthony Treviso · Founder and responsible editor
- Clinical-review boundary
- Not independently medically reviewed.